psalexa
logo

Hyperlipidemia Therapeutics Pipeline Analysis

Hyperlipidemia Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11140
Available Format:

Hyperlipidemia is a disease that involves high levels of cholesterol and lipids in the blood. The main cause of the disease is higher cholesterol levels, decreased physical activity and old age. The risks associated with the hyperlipidemia include high blood pressure, heart attacks and stroke. According to the data published by the Centers for Disease Control and Prevention, nearly 31 million adult Americans had a total cholesterol level greater than 240 mg/dL, in 2014. Women have a higher chance of developing hyperlipidemia as compared to men. CJ HealthCare Corp. is in the process of developing CJ-30056 CJ-30061, and CJ-30060 for the treatment of hyperlipidemia. Some of the companies having a pipeline of hyperlipidemia include Gordagen Pharmaceuticals Pty. Ltd., Yuhan Corporation and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities, including information about clinical results, designations, collaborations, licencing, grants, technology and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry